New combo shows promise against tough pancreatic tumors
NCT ID NCT03991962
First seen Nov 10, 2025 · Last updated May 01, 2026 · Updated 28 times
Summary
This study tests a two-step treatment for people with pancreatic cancer that is too advanced for surgery but hasn't spread to other organs. First, patients receive a stronger chemotherapy regimen called modified FOLFIRINOX, followed by precise, high-dose radiation (SBRT). The goal is to see if this approach delays cancer growth better than older treatments. About 28 participants are being followed for up to 3 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yale University School of Medicine
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.